Relation between chromosomal aberrations and radiation dose during the process of TBI

Shoji Kutsuki, Noriko Ihara, Naoyuki Shigematsu, Shinichiro Okamoto, Atsushi Kubo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: The purposes of this study were (1) to consider the dose-response relationship in-vivo at high dose range by using the Colcemid method, which begins with predicting the risk of future late complication caused by a fixed dose of chromosomal aberration of peripheral lymphocytes after radiation emission and (2) to compare in-vivo and in-vitro dose-responses for chromosomal aberrations in lymphocytes of cancer patients undergoing total body irradiation (TBI). Methods: Eight patients diagnosed with hematological malignancies entered this study. TBI planning with a 6 MV linear accelerator consisted of 4 Gy/2 fractions/day, and the total treatment dose was 12 Gy. Results: At the observable dose range of up to 10 Gy, the unstable chromosomal aberrations of both dicentrics and fragments increased with the increment of irradiated dose, regardless of in-vivo or in-vitro irradiated samples. However, the average number of dicentrics and fragments obtained from in-vitro samples was found to be higher than that for in-vivo samples. Conclusion: This result strongly suggests that in-vivo dose-response curves are necessary to estimate the absorbed dose in-vivo. In-vivo dose-response curves obtained from cancer patients would be very important for standard curves for biodosimetry.

Original languageEnglish
Pages (from-to)37-42
Number of pages6
JournalRadiation Medicine - Medical Imaging and Radiation Oncology
Volume23
Issue number1
Publication statusPublished - 2005 Feb

Fingerprint

Whole-Body Irradiation
Chromosome Aberrations
aberration
Radiation
dosage
irradiation
radiation
Lymphocytes
Demecolcine
Particle Accelerators
Hematologic Neoplasms
Neoplasms
lymphocytes
curves
cancer
fragments
In Vitro Techniques
linear accelerators
planning
Therapeutics

Keywords

  • Biodosimetry
  • Chromosomal aberration
  • Total body irradiation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Relation between chromosomal aberrations and radiation dose during the process of TBI. / Kutsuki, Shoji; Ihara, Noriko; Shigematsu, Naoyuki; Okamoto, Shinichiro; Kubo, Atsushi.

In: Radiation Medicine - Medical Imaging and Radiation Oncology, Vol. 23, No. 1, 02.2005, p. 37-42.

Research output: Contribution to journalArticle

@article{b6934b7435e7414aaf727b24ac6007d8,
title = "Relation between chromosomal aberrations and radiation dose during the process of TBI",
abstract = "Purpose: The purposes of this study were (1) to consider the dose-response relationship in-vivo at high dose range by using the Colcemid method, which begins with predicting the risk of future late complication caused by a fixed dose of chromosomal aberration of peripheral lymphocytes after radiation emission and (2) to compare in-vivo and in-vitro dose-responses for chromosomal aberrations in lymphocytes of cancer patients undergoing total body irradiation (TBI). Methods: Eight patients diagnosed with hematological malignancies entered this study. TBI planning with a 6 MV linear accelerator consisted of 4 Gy/2 fractions/day, and the total treatment dose was 12 Gy. Results: At the observable dose range of up to 10 Gy, the unstable chromosomal aberrations of both dicentrics and fragments increased with the increment of irradiated dose, regardless of in-vivo or in-vitro irradiated samples. However, the average number of dicentrics and fragments obtained from in-vitro samples was found to be higher than that for in-vivo samples. Conclusion: This result strongly suggests that in-vivo dose-response curves are necessary to estimate the absorbed dose in-vivo. In-vivo dose-response curves obtained from cancer patients would be very important for standard curves for biodosimetry.",
keywords = "Biodosimetry, Chromosomal aberration, Total body irradiation",
author = "Shoji Kutsuki and Noriko Ihara and Naoyuki Shigematsu and Shinichiro Okamoto and Atsushi Kubo",
year = "2005",
month = "2",
language = "English",
volume = "23",
pages = "37--42",
journal = "Japanese Journal of Radiology",
issn = "1867-1071",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Relation between chromosomal aberrations and radiation dose during the process of TBI

AU - Kutsuki, Shoji

AU - Ihara, Noriko

AU - Shigematsu, Naoyuki

AU - Okamoto, Shinichiro

AU - Kubo, Atsushi

PY - 2005/2

Y1 - 2005/2

N2 - Purpose: The purposes of this study were (1) to consider the dose-response relationship in-vivo at high dose range by using the Colcemid method, which begins with predicting the risk of future late complication caused by a fixed dose of chromosomal aberration of peripheral lymphocytes after radiation emission and (2) to compare in-vivo and in-vitro dose-responses for chromosomal aberrations in lymphocytes of cancer patients undergoing total body irradiation (TBI). Methods: Eight patients diagnosed with hematological malignancies entered this study. TBI planning with a 6 MV linear accelerator consisted of 4 Gy/2 fractions/day, and the total treatment dose was 12 Gy. Results: At the observable dose range of up to 10 Gy, the unstable chromosomal aberrations of both dicentrics and fragments increased with the increment of irradiated dose, regardless of in-vivo or in-vitro irradiated samples. However, the average number of dicentrics and fragments obtained from in-vitro samples was found to be higher than that for in-vivo samples. Conclusion: This result strongly suggests that in-vivo dose-response curves are necessary to estimate the absorbed dose in-vivo. In-vivo dose-response curves obtained from cancer patients would be very important for standard curves for biodosimetry.

AB - Purpose: The purposes of this study were (1) to consider the dose-response relationship in-vivo at high dose range by using the Colcemid method, which begins with predicting the risk of future late complication caused by a fixed dose of chromosomal aberration of peripheral lymphocytes after radiation emission and (2) to compare in-vivo and in-vitro dose-responses for chromosomal aberrations in lymphocytes of cancer patients undergoing total body irradiation (TBI). Methods: Eight patients diagnosed with hematological malignancies entered this study. TBI planning with a 6 MV linear accelerator consisted of 4 Gy/2 fractions/day, and the total treatment dose was 12 Gy. Results: At the observable dose range of up to 10 Gy, the unstable chromosomal aberrations of both dicentrics and fragments increased with the increment of irradiated dose, regardless of in-vivo or in-vitro irradiated samples. However, the average number of dicentrics and fragments obtained from in-vitro samples was found to be higher than that for in-vivo samples. Conclusion: This result strongly suggests that in-vivo dose-response curves are necessary to estimate the absorbed dose in-vivo. In-vivo dose-response curves obtained from cancer patients would be very important for standard curves for biodosimetry.

KW - Biodosimetry

KW - Chromosomal aberration

KW - Total body irradiation

UR - http://www.scopus.com/inward/record.url?scp=15744393646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744393646&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 37

EP - 42

JO - Japanese Journal of Radiology

JF - Japanese Journal of Radiology

SN - 1867-1071

IS - 1

ER -